CPT® Code 79300

1. Indications

Radiopharmaceutical therapy by interstitial radioactive colloid administration is indicated for the treatment of specific diseases or conditions that require targeted radiation therapy. The following are the explicitly provided indications for this procedure:

• Treatment of tumors This therapy is often utilized for the management of certain types of tumors, where localized radiation can effectively target and destroy cancerous cells.
• Management of hyperthyroidism In cases of hyperthyroidism, this therapy can help in reducing the overactivity of the thyroid gland by delivering radioactive isotopes that inhibit thyroid function.
• Palliative care It may also be indicated for palliative treatment, providing relief from symptoms associated with advanced cancer or other serious conditions.

2. Procedure

The procedure for radiopharmaceutical therapy by interstitial radioactive colloid administration involves several critical steps to ensure effective treatment. Each step is designed to facilitate the safe and accurate delivery of the radioactive colloid to the targeted area.

• Step 1: Preparation of the patient The patient is prepared for the procedure, which may include obtaining informed consent, reviewing medical history, and conducting any necessary imaging studies to identify the precise location for the administration of the radioisotope.
• Step 2: Preparation of the radiopharmaceutical The radiopharmaceutical, which consists of the selected radioisotope suspended in a colloid solution, is prepared in a sterile environment. This preparation ensures that the solution is safe for administration and that the correct dosage is achieved.
• Step 3: Administration of the colloid Using a syringe and needle, the healthcare provider carefully injects the colloid solution containing the radioisotope into the targeted tissue. This step requires precision to ensure that the radioactive material is delivered accurately to the intended site.
• Step 4: Monitoring After the administration, the patient is monitored for any immediate reactions or side effects. This monitoring is crucial to ensure the patient's safety and to assess the initial effectiveness of the treatment.

3. Post-Procedure

Following the procedure, patients may require specific post-procedure care to ensure optimal recovery and effectiveness of the treatment. Patients are typically monitored for any adverse reactions to the radiopharmaceutical. Additionally, they may receive instructions regarding precautions to minimize radiation exposure to others, such as maintaining a safe distance from pregnant women and young children for a specified period. Follow-up appointments may be scheduled to evaluate the treatment's effectiveness and to monitor the patient's overall health and recovery.